Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Newborn skin is uniquely prepared to adapt to new environments compared to adult skin.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Plant extracts can benefit skin but must be safe and high-quality.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.

Higher androgen levels are linked to more severe hair growth in hirsute women.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

Ongoing research and innovation are crucial for improving skin care and treatment.

The G allele of IFITM3 rs12252 is linked to more severe COVID-19.

Lower LDL-c levels predict higher COVID-19 mortality.

COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.